ENCBS295AAA / in vitro differentiated cells

Summary

Status
released
Term name
mesodermal cell
Term ID
CL:0000222
Summary
Homo sapiens female embryo mesodermal in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 2 days, 6 ng/mL Activin A for 2 days, 10 ng/mL Bone morphogenetic protein 4 for 2 days
Description
H7 hESC to cardiomyocyte, endothelial and smooth muscle cell differentiation treatment for 2 days
Originated from biosample
ENCBS336AYE

Attribution

ENCODE2 project
Lab
John Stamatoyannopoulos, UW
Award PI
John Stamatoyannopoulos, UW
Submitted by
John Stamatoyannopoulos
Source
Unknown Source
Project
ENCODE
Aliases
john-stamatoyannopoulos:DS14732

Treatment details

Treatment
5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 2 days
Type
protein
Treatment
6 ng/mL Activin A (CHEBI:81351) for 2 days
Type
chemical
Treatment
10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 2 days
Type
protein

Donor information

Status
released
Accession
ENCDO221AAA
Aliases
encode:donor of H7
Species
Homo sapiens
Life stage
embryonic
Sex
female
External resources

Documents

differentiation protocol
Description: H7 Mesoderm 2-day Differentiation Protocol
Submitted by
John Stamatoyannopoulos
Lab
John Stamatoyannopoulos, UW